Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENSIFENTRINE vs EPCORITAMAB-BYSP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENSIFENTRINE vs EPCORITAMAB-BYSP: Safety Overview

Metric ENSIFENTRINE EPCORITAMAB-BYSP
Total FAERS Reports 410 978
Deaths Reported 2 341
Death Rate 0.5% 34.9%
Hospitalizations 77 199
Average Patient Age 71.7 yrs 71.6 yrs
% Female Patients 51.6% 41.6%
FDA Approval Date Jun 26, 2024 N/A
Manufacturer Verona Pharma, Inc. N/A
Route RESPIRATORY (INHALATION) N/A
Marketing Status Prescription Prescription